Patient Perceptions of Side Effects of Cancer Chemoradiotherapy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 62
- 试验地点
- 1
- 主要终点
- Identify the most common type of side effects as perceived by patients on the last day of radiation treatment
研究概览
简要总结
This study is asking patients who are undergoing radiation therapy with or without chemotherapy on how well they evaluate their side effects on the last day of treatment. This study is not to change health outcomes of the patients in this study. Asking patients to rank side effects in order of which ones bother them the most may help researchers identify the most troubling side effects of cancer treatment.
详细描述
PRIMARY OBJECTIVES:
I. To examine the perceptions of side effects and their subjective severity of patients treated with radiotherapy with and without concurrent chemotherapy at Los Angeles County (LAC) + University of Southern California (USC) Medical Center.
SECONDARY OBJECTIVES:
I. To identify the most troubling side effects of patients treated with radiotherapy with and without concurrent chemotherapy at LAC+USC Medical Center.
II. To evaluate the impact of chemotherapy combined with radiation therapy, in regards to whether or not perceptions of side effects are altered by what cancer treatment is given.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of cancer
- •Has received at least 4 consecutive weeks of definitive radiation treatment, with or without concurrent chemotherapy
- •Has not received greater than 4 weeks of chemotherapy prior to radiation therapy start
- •Ability to understand and the willingness to sign a written informed consent
排除标准
- •Patients with either a central nervous system (CNS)-primary cancer or with brain metastases
结局指标
主要结局
Identify the most common type of side effects as perceived by patients on the last day of radiation treatment
时间窗: Up to 1 year
Tables and bar charts will be used to display the 10-20 highest ranked side effects overall, by sex and concurrent chemotherapy. Descriptive statistics such as means and standard deviation will be used.
次要结局
未报告次要终点
